
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

News has emerged that Novartis plans to close down its Cell and Gene Therapies unit, with up to 120 workers …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

